Skip to main content
. 2016 Jan 28;27(7):2164–2176. doi: 10.1681/ASN.2015040369

Table 1.

Metabolic parameters, renal function, BP, and requirements for antihypertensive treatment in study arms

Parameter and Study Moment KD (n=104) LPD (n=103) P Valuec
Renal function
 eGFR (ml/min)
  Baseline 18.0 (15.5 to 20.1) 17.9 (14.3 to 19.3) 0.68
  End of study 15.1 (13.2 to 17.4) 10.8 (9.0 to 12.2) <0.01
 Proteinuria (g/d)a
  Baseline 0.88 (0.79 to 0.96) 0.88 (0.82 to 0.96) 0.73
  End of study 0.78 (0.67 to 0.85) 0.67 (0.57 to 0.81) 0.06
BPb
 Mean arterial BP (mmHg)
  Baseline 86 (78 to 96) 93 (86 to 96) 0.06
  End of study 90 (86 to 92) 87 (83 to 93) 0.42
 Patients with optimal BP controlc (%)
  Baseline 91 89 0.67
  End of study 85 84 0.95
 Patients on antihypertensive drugs (%)
  Baseline 86 89 0.55
  End of study 88 93 0.24
 Patients receiving ACEIs and/or ARBs (%)
  Baseline 71 71 0.96
  End of study 71 70 0.84
Nitrogen waste products
 Serum urea (mg/dl)d
  Baseline 187 (164 to 225) 213 (183 to 248) 0.73
  End of study 122 (114 to 127) 226 (191 to 252) <0.01
 Serum uric acid (mg/dl)e
  Baseline 6.5 (6.5 to 6.6) 6.3 (6.2 to 6.3) 0.06
  End of study 6.0 (5.8 to 6.1) 6.3 (6.1 to 6.4) 0.01
Acid-base balance
 Serum bicarbonate (mEq/L)
  Baseline 16.7 (15.8 to 17.6) 16.8 (15.9 to 17.8) 0.98
  End of study 22.9 (21.7 to 24.1) 16.2 (15.4 to 16.9) <0.01
Sodium bicarbonate supplementation
 Patients treated (%)
  Baseline 36 40 0.53
  End of study 29 51 <0.01
 Prescribed dose (g/d)
  Baseline 2.0 (2.0 to 2.4) 2.0 (1.6 to 2.4) 0.63
  End of study 2.2 (2.0 to 2.6) 3.2 (2.4 to 3.6) 0.03
Calcium-phosphorus metabolism
 Serum calcium (mg/dl)
  Baseline 3.8 (3.7 to 3.9) 3.8 (3.7 to 4.0) 0.61
  End of study 4.4 (4.3 to 4.5) 3.9 (3.7 to 3.9) <0.01
 Serum phosphates (mg/dl)
  Baseline 5.9 (5.3 to 6.2) 5.8 (5.2 to 6.1) 0.68
  End of study 4.4 (4.3 to 4.5) 6.2 (5.8 to 6.5) <0.01
Calcium supplementation
 Patients treated (%)
  Baseline 46 40 0.35
  End of study 49 51 0.72
 Prescribed dose (g/d)
  Baseline 6.1 (5.7 to 6.5) 6.0 (5.6 to 6.5) 0.91
  End of study 6.3 (6.0 to 6.6) 6.9 (6.6 to 7.3) <0.01
 Vitamin D therapy (patients %)
  Baseline 22 30 0.19
  End of study 22 54 <0.01

Values at randomization were compared with those at the end of the study (i.e., reach of the EPP or end of the follow-up period). Data are shown as median and 95% CI. To convert eGFR in milliliters per minute to milliliters per second, multiply by 0.01667. To convert serum urea in milligrams per deciliter to millimoles per liter, multiply by 0.357. To convert serum urea in milligrams per deciliter to BUN in milligrams per deciliter, divide by 2.14. To convert serum creatinine in milligrams per deciliter to ± moles per liter, multiply by 88.4. To convert serum bicarbonate in equivalents per liter to millimoles per liter, multiply by 1. To convert serum calcium in milligrams per deciliter to millimoles per liter, multiply by 0.2495. To convert serum phosphates in milligrams per deciliter to millimoles per liter, multiply by 0.3229. To convert serum albumin in grams per deciliter to grams per liter, multiply by 10.

c

Arterial BP<130/75 mmHg.